Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer

Published:2017-03 Issue: Volume:112 Page:224-233
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Najlah Mohammad,Ahmed Zahima,Iqbal Mohammed,Wang Zhipeng,Tawari Patrica,Wang Weiguang,McConville Christopher

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference63 articles.

1. www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-key-statistics.

2. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009;Houston;Lung Cancer,2014

3. Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer;Ohgino;Lung Cancer,2014

4. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer;Yoda;Lung Cancer,2014

5. Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: a meta-analysis of randomized controlled clinical trials;Zhao;Lung Cancer,2014

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Study of Oral Disulfiram Suspension and Topical Transdermal Nano-Invasomes Gel in Wistar Rats;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-08-19

2. Carrier‐Free Disulfiram Based Nanomedicine for Enhanced Cancer Therapy;ChemNanoMat;2024-07-05

3. Quality-by-design-based microemulsion of disulfiram for repurposing in melanoma and breast cancer therapy;Therapeutic Delivery;2024-07

4. Exploring Disulfiram’s Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy;Nanomaterials;2024-06-30

5. Non-small Cell Lung Cancer Treatment: Current Status of Drug Repurposing and Nanoparticle-based Drug Delivery Systems;Turkish Journal of Biology;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3